Core Viewpoint - Rosen Law Firm is reminding investors who purchased Fortrea Holdings, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline on August 1, 2025, for a class action lawsuit [1][2]. Group 1: Class Action Details - Investors who bought Fortrea securities between July 3, 2023, and February 28, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must act by the lead plaintiff deadline to participate [2]. - The lawsuit alleges that Fortrea made false and misleading statements regarding its revenue projections and cost savings, which inflated its EBITDA targets for 2025 [4]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in this area [3]. - The firm has secured significant settlements for investors, including over $438 million in 2019 alone, and has been consistently ranked among the top firms for securities class action settlements [3].

Core Viewpoint - A class action lawsuit has been filed against Fortrea Holdings Inc. for allegedly misleading investors regarding its financial performance and projections following its spin-off from Labcorp Holdings Inc. [1][3][5] Company Overview - Fortrea Holdings was spun off from Labcorp Holdings in June 2023 and operates as a standalone publicly traded company [3]. - The company entered into transition services agreements with Labcorp, which include various administrative and IT support services [3]. Financial Performance - On March 3, 2025, Fortrea announced that its revenue and adjusted EBITDA targets for 2025 were not meeting prior expectations, leading to a significant stock price drop of 25.05%, closing at $10.38 per share [4]. - The company indicated that its Pre-Spin projects were underperforming, with less revenue and profitability than anticipated for 2025 [4]. Allegations in the Lawsuit - The complaint alleges that Fortrea overestimated revenue contributions from Pre-Spin projects and overstated potential cost savings from exiting transition services agreements [5]. - It is claimed that the company's previously announced EBITDA targets for 2025 were inflated, misrepresenting the viability of its post-spin business model [5].

Core Viewpoint - A lawsuit has been filed against Fortrea Holdings Inc. and its senior executives for potential violations of federal securities laws, following allegations of overstating cost savings and revenue projections related to transition services agreements after its spin-off from Labcorp [1][2][4]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Southern District of New York, specifically titled Deslande v. Fortrea Holdings Inc., et al., No. 1:25-cv-04630 [2]. - Investors have until August 1, 2025, to request to be appointed to lead the case [2]. Group 2: Company Background - Fortrea is a global contract research organization that provides biopharmaceutical product and medical device development solutions, having been spun off from Labcorp in June 2023 [3]. Group 3: Allegations and Financial Impact - Allegations state that Fortrea exaggerated the cost savings and margin improvements expected from exiting transition services agreements, as well as the revenue from pre-spin projects [4]. - Following a report from Jefferies on September 25, 2024, which indicated that the anticipated cost savings were not as significant as claimed, Fortrea's stock price fell by $2.73, or over 12%, from $22.21 to $19.48 per share [5]. - On March 3, 2025, Fortrea announced disappointing Q4 and full-year 2024 results, leading to a further decline in stock price by $3.47, or over 25%, from $13.85 to $10.38 per share [6].

Core Viewpoint - Fortrea Holdings Inc. is facing a class action lawsuit for allegedly misleading investors regarding its financial projections and business model following its spin-off from Labcorp [1][3][4]. Company Overview - Fortrea is a global clinical research organization (CRO) that assists in the development of pharmaceutical and medical device products. It was spun off from Labcorp in June 2023 and had ongoing long-term projects at that time [3]. Allegations of Misleading Information - The lawsuit claims that Fortrea overestimated the revenue from its Pre-Spin Projects for 2025, overstated cost savings from phasing out transition service agreements (TSAs), and inflated its EBITDA targets for 2025, presenting an overly optimistic view of its post-spin-off business model [5]. Market Reactions and Stock Performance - On September 25, 2024, Jefferies downgraded Fortrea from Buy to Hold, citing weaknesses in the CRO model and a lack of real cost savings, leading to a stock drop of over 12% [5]. - Following the abrupt cancellation of two conferences, Baird Equity Research downgraded Fortrea to Neutral on December 6, 2024, resulting in an additional stock decline of 8% [5]. - On March 3, 2025, Fortrea reported disappointing Q4 and full-year 2024 results, admitting that its revenue and EBITDA goals for 2025 were unrealistic, causing the stock to drop more than 25% [5].

Core Viewpoint - Fortrea Holdings Inc. is facing a class action securities lawsuit due to alleged securities fraud that affected investors between July 3, 2023, and February 28, 2025 [1][2] Group 1: Allegations of Fraud - The lawsuit claims that Fortrea Holdings Inc. overestimated revenue contributions from its long-term projects, known as the Pre-Spin Projects, for the year 2025 [2] - It is alleged that the company overstated potential cost savings from exiting transition services agreements [2] - The previously announced EBITDA targets for 2025 were reportedly inflated, leading to an overstatement of the company's post-spin-off business model viability and financial prospects [2] - The public statements made by the company were claimed to be materially false and misleading throughout the relevant period [2] Group 2: Legal Process and Participation - Investors who suffered losses during the specified timeframe have until August 1, 2025, to request appointment as lead plaintiff in the lawsuit [3] - Participation in the lawsuit does not require serving as a lead plaintiff, and class members may be entitled to compensation without any out-of-pocket costs [3] Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [4] - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the leading securities litigation firms in the United States [4]

NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Fortrea Holdings Inc. ("Fortrea Holdings Inc." or the "Company") (NASDAQ: FTRE) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Fortrea Holdings Inc. investors who were adversely affected by alleged securities fraud between July 3, 2023 and February 28, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/psl ...

NEW YORK, July 17, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Fortrea Holdings Inc. (NASDAQ: FTRE).Shareholders who purchased shares of FTRE during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/fortrea-holdings-inc-loss-submission-form/?id=156852&from=4 CLASS PERIOD: July 3, 2 ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Fortrea Holdings, Inc. securities during the specified class period of the upcoming lead plaintiff deadline on August 1, 2025, and the potential for compensation without out-of-pocket costs [1][2]. Group 1: Class Action Details - Investors who bought Fortrea securities between July 3, 2023, and February 28, 2025, may be eligible to join a class action lawsuit [1][2]. - A class action lawsuit has already been filed, and interested parties must act by the lead plaintiff deadline [2][6]. - The lawsuit alleges that Fortrea made false and misleading statements regarding its revenue projections and cost savings, which inflated its EBITDA targets for 2025 [4]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [3]. - The firm has achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time, and has recovered hundreds of millions for investors [3]. - In 2019, the firm secured over $438 million for investors, showcasing its effectiveness in litigation [3].

Core Viewpoint - A lawsuit is pending against Fortrea Holdings Inc. for alleged violations of securities laws, with claims that the company made misleading statements regarding its revenue projections and cost savings [2]. Group 1: Lawsuit Details - An investor filed a lawsuit on May 23, 2025, alleging that Fortrea Holdings Inc. overstated the revenue contributions from its Pre-Spin Projects for 2025 [2]. - The lawsuit claims that Fortrea exaggerated the cost savings expected from exiting Transition Services Agreements (TSAs), leading to inflated EBITDA targets for 2025 [2]. - The plaintiff asserts that the company's public statements regarding its post-Spin-Off business model and financial prospects were materially false and misleading [2]. Group 2: Investor Information - Shareholders who purchased shares of Fortrea Holdings Inc. prior to July 2023 and continue to hold them are encouraged to contact the Shareholders Foundation for options [1][3]. - The Shareholders Foundation provides services related to shareholder issues, including information on securities class actions and legal news relevant to the financial market [3].

SAN DIEGO, July 16, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP, announces that a class action lawsuit has commenced on behalf of investors of Fortrea Holdings Inc. (NASDAQ: FTRE). The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. Specifically, the Complaint alleges: (i) Fortrea overestimated the amount of revenue the Pre-Spin Projects were likely to co ...